Written By: Biopharma Informatic Team
The Houston-based clinical research investigator network joins the global GI community at DDW 2026, held from May 2nd to 5th, to build partnerships and advance its mission of accessible, high-quality clinical research.
Chicago, IL — Chicago is where DDW pulls together some of the sharpest minds in gastroenterology and hepatology. This May, McCormick Place plays host to DDW 2026 from May 2nd to 5th, with over 13,000 professionals expected to walk through those doors and Biopharma Informatic will
DDW is widely regarded as the premier global meeting for digestive health professionals. This year's event spans four days and features over 400 scientific sessions, 4,300 oral abstract and ePoster presentations and an exhibit hall hosting more than 300 companies. Covering 14 dedicated education tracks from Inflammatory Bowel Disease and Hepatology to Pancreatic Disease and Gut-Brain Interaction, DDW 2026 is where the field's most important conversations are happening.
DDW has a way of bringing the clinical research world together in one place and 2026 continues that trend. The event brings science, medicine and industry together, where research is linked to real-world patient needs. As the GI and hepatology field continues to shift, being present at DDW is seen as important rather than optional to keep up.
The Biopharma Informatic team will be attending DDW 2026, spending time with researchers, sponsors and clinical professionals across the four days. Our focus is clear: to connect with the right people, have the right conversations and explore where Biopharma Informatic's clinical research expertise can drive shared value. Whether it be in sessions or on the exhibit floor, the team will be there, all present and purposeful.
The clinical research landscape in GI and hepatology is shifting. New therapeutic targets, evolving trial methodologies and growing patient populations are reshaping what's possible. Biopharma Informatic is committed to being part of that momentum as an active contributor to the clinical research ecosystem that makes breakthrough treatments a reality for patients.
As part of our work in this space, we are also conducting clinical research in eosinophilic esophagitis, focusing on improving understanding of the condition and exploring potential treatment approaches.
This ongoing work aligns closely with the broader direction of GI research, making forums like DDW a meaningful place to see where things are headed next and how we can continue contributing to that progress.
Events like DDW remind us why this work matters. You're in a room with the people who are genuinely pushing the field forward and for us, that's both an inspiration and an invitation.
Shuja Naqvi Chief Executive Officer
DDW 2026 is one stop on a longer journey. Biopharma Informatic keeps building more capabilities, a wider network and partnerships that lead to better-run, better-designed trials. What gets started in Chicago will carry forward into the work the team does every day and that's really the point of showing up.
Phone: (281) 944-3610
Email: [email protected]
Biopharma Informatic is a Houston-based clinical research investigator network dedicated to advancing clinical research through expertise, accessibility and meaningful industry collaboration.